ATE253910T1 - Transdermale verabreichung von lasofoxifen - Google Patents

Transdermale verabreichung von lasofoxifen

Info

Publication number
ATE253910T1
ATE253910T1 AT01939751T AT01939751T ATE253910T1 AT E253910 T1 ATE253910 T1 AT E253910T1 AT 01939751 T AT01939751 T AT 01939751T AT 01939751 T AT01939751 T AT 01939751T AT E253910 T1 ATE253910 T1 AT E253910T1
Authority
AT
Austria
Prior art keywords
devices
carrier vehicle
reservoir
lasofoxifene
drug
Prior art date
Application number
AT01939751T
Other languages
English (en)
Inventor
David Fikstad
Danyi Quan
Original Assignee
Watson Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Watson Pharmaceuticals Inc filed Critical Watson Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE253910T1 publication Critical patent/ATE253910T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01939751T 2000-06-01 2001-05-31 Transdermale verabreichung von lasofoxifen ATE253910T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20878900P 2000-06-01 2000-06-01
PCT/US2001/017567 WO2001091724A2 (en) 2000-06-01 2001-05-31 Transdermal delivery of lasofoxifene

Publications (1)

Publication Number Publication Date
ATE253910T1 true ATE253910T1 (de) 2003-11-15

Family

ID=22776068

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01939751T ATE253910T1 (de) 2000-06-01 2001-05-31 Transdermale verabreichung von lasofoxifen

Country Status (24)

Country Link
US (1) US20020037311A1 (de)
EP (1) EP1229909B1 (de)
JP (1) JP2003534368A (de)
KR (1) KR100795870B1 (de)
CN (1) CN1400897A (de)
AT (1) ATE253910T1 (de)
AU (2) AU785199B2 (de)
BR (1) BR0106680A (de)
CA (1) CA2380769A1 (de)
CZ (1) CZ2002488A3 (de)
DE (1) DE60101206T2 (de)
DK (1) DK1229909T3 (de)
ES (1) ES2210168T3 (de)
HK (1) HK1052472A1 (de)
HU (1) HUP0202592A3 (de)
IL (2) IL147640A0 (de)
MX (1) MXPA02001152A (de)
NZ (1) NZ516582A (de)
PL (1) PL201222B1 (de)
PT (1) PT1229909E (de)
RU (1) RU2328276C2 (de)
TR (1) TR200400241T4 (de)
WO (1) WO2001091724A2 (de)
ZA (1) ZA200200519B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7804912B2 (en) * 2004-09-23 2010-09-28 Motorola, Inc. Method and apparatus for encryption of over-the-air communications in a wireless communication system
US7564908B2 (en) * 2004-09-23 2009-07-21 Motorola, Inc. Method and apparatus for encryption of over-the-air communications in a wireless communication system
FR2905601A1 (fr) * 2006-09-11 2008-03-14 Innoderm Sarl Utilisation de derives oleiques comme methode et composition favorisant la penetration cutanee des actifs contenus dans les compositions cosmetiques, pharmaceutiques ou dermatologiques.
US20100292660A1 (en) * 2007-07-10 2010-11-18 Agis Kydonieus Dermal delivery device with ultrasonic weld
CN101801321B (zh) * 2007-07-10 2014-07-02 敏捷治疗公司 原位密封的经皮输送装置
US20140378424A1 (en) * 2011-12-30 2014-12-25 Rosscreening, Inc. Estrogen receptor modulators for reducing body weight
CN103751138A (zh) * 2013-12-31 2014-04-30 北京万全德众医药生物技术有限公司 一种含酒石酸拉索昔芬的口腔崩解片及其制备方法
CN103830207A (zh) * 2014-03-14 2014-06-04 崔书豪 一种酒石酸拉索昔芬贴膏剂
CN103830196A (zh) * 2014-03-14 2014-06-04 王志刚 一种酒石酸拉索昔芬分散片及其制备方法
BR112018001435A2 (pt) * 2015-07-24 2018-09-11 Kimberly Clark Co métodos para entrega linfática de agentes ativos
ES2891523T3 (es) * 2015-07-24 2022-01-28 Sorrento Therapeutics Inc Procedimientos para un mejor suministro de agentes activos en los tumores

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1170360A (zh) * 1994-12-21 1998-01-14 瑟垃技术有限公司 具有粘性贴面和剥离密封圆片的经皮输送系统
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
IL120265A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to treat osteoporosis - polyphosphonates or progestins and estrogen agonists
US6034102A (en) * 1996-11-15 2000-03-07 Pfizer Inc Atherosclerosis treatment
US6203817B1 (en) * 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
CO5170459A1 (es) * 1999-06-01 2002-06-27 Pfizer Prod Inc Terapia transdermica con agonistas-antagonistas de estrogenos len-ol, administrados mediante medios transdermicos

Also Published As

Publication number Publication date
EP1229909A2 (de) 2002-08-14
RU2002105378A (ru) 2003-11-10
DE60101206D1 (de) 2003-12-18
PL201222B1 (pl) 2009-03-31
RU2328276C2 (ru) 2008-07-10
HUP0202592A2 (hu) 2002-12-28
EP1229909B1 (de) 2003-11-12
WO2001091724A3 (en) 2002-05-30
PT1229909E (pt) 2004-04-30
AU785199B2 (en) 2006-11-02
BR0106680A (pt) 2002-04-30
ZA200200519B (en) 2003-04-22
WO2001091724A2 (en) 2001-12-06
AU6523501A (en) 2001-12-11
KR100795870B1 (ko) 2008-01-21
HUP0202592A3 (en) 2003-07-28
PL354628A1 (en) 2004-02-09
IL147640A0 (en) 2002-08-14
KR20030025219A (ko) 2003-03-28
HK1052472A1 (zh) 2003-09-19
JP2003534368A (ja) 2003-11-18
CA2380769A1 (en) 2001-12-06
IL147640A (en) 2007-03-08
CN1400897A (zh) 2003-03-05
MXPA02001152A (es) 2002-08-20
US20020037311A1 (en) 2002-03-28
DE60101206T2 (de) 2004-09-02
TR200400241T4 (tr) 2004-04-21
DK1229909T3 (da) 2004-03-15
CZ2002488A3 (cs) 2002-06-12
AU2007200426A1 (en) 2007-02-22
NZ516582A (en) 2004-08-27
ES2210168T3 (es) 2004-07-01

Similar Documents

Publication Publication Date Title
US10709669B2 (en) Microreservoir system based on polysiloxanes and ambiphilic solvents
DE60023520D1 (de) Flüssiges hochvisköses system mit gesteuerter freisetzung und medizinische oder chirurgische vorrichtung
WO2004052336A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
RU2003128642A (ru) Улучшенная чрескожная терапевтическая система для лечения болезни паркинсона
DE69326461T2 (de) Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung
ATE253910T1 (de) Transdermale verabreichung von lasofoxifen
ATE263577T1 (de) Transdermales verabreichungssystem
DE602005011653D1 (de) Medizinprodukt mit gewebeabhängiger arzneimittelelution
ATE302598T1 (de) Transdermale vorrichtung zur arzneistoffverabreichung mit einem polyurethanwirkstoffreservoir
DE69637768D1 (de) Arzneitmittel zur kontrollierten freisetzung löslicher rezeptoren
DE69506007T2 (de) Transdermales system zur gleichzeitigen verabreichung von mehreren wirkstoffen
RU2003133217A (ru) Чрескожная терапевтическая система для лечения болезни паркинсона, индуцирующая высокие уровни ротиготина в плазме
TW200514590A (en) Hydrophilic adhesives for delivery of herbal medicines
HUP0402213A2 (hu) Propilénglikolmonokaprilátot tartalmazó szteroid hormontartalmú transzdermális terápiás rendszer
KR100940245B1 (ko) 경피 약물 전달 시스템에 유용한 비반응성 접착제
AU2003215657A1 (en) Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion.
WO2001064149A1 (en) Improved transdermal drug patch
WO2001058408A3 (en) Multi-purpose drug and heat therapy treatment system
JP4430120B2 (ja) 抗真菌症用貼付剤
MXPA02009103A (es) Sistema terapeutico transdermal para la administracion de lerisetron.
MY129063A (en) Transdermal delivery of lasofoxifene
AU1174400A (en) Retro-inversion peptides that target git transport receptors and related methods
CN118103036A (zh) 用于透皮施用替扎尼定的透皮治疗系统
FR2806625B1 (fr) Dispositif matriciel pour l'administration transdermique de rilmenidine et son procede de preparation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1229909

Country of ref document: EP

REN Ceased due to non-payment of the annual fee